CDC approves Moderna and J&J boosters, plus mixing shots
The Centers for Disease Control and Prevention on Thursday gave final approval for certain people to receive booster doses of the Moderna and Johnson & Johnson COVID-19 vaccines.
The agency also approved the option of mixing and matching, so people can receive a booster from a different manufacturer than their initial dose.
Those who are eligible for the Moderna booster — including people 65 and older, nursing home residents, and those 50 and up who are at severe risk if they become infected by COVID-19 — and all Johnson & Johnson vaccine recipients can sign up for boosters starting Friday. For Moderna, recipients can get a half-dose booster six months after being fully vaccinated, while those who got the single-dose Johnson & Johnson vaccine can get a booster at least two months later.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"These past 20 months have taught us many things, but mostly to have humility," CDC Director Dr. Rochelle Walensky said. "We are constantly learning about this virus, growing the evidence base and accumulating more data."
On Wednesday, the Food and Drug Administration authorized booster doses of the vaccines, followed by a CDC advisory panel earlier Thursday, leaving Walensky to make the final call on Thursday night.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
A running list of everything Trump has named or renamed after himselfIn Depth The Kennedy Center is the latest thing to be slapped with Trump’s name
-
Do oil companies really want to invest in Venezuela?Today’s Big Question Trump claims control over crude reserves, but challenges loom
-
‘Despite the social benefits of venting, people can easily overdo it’Instant Opinion Opinion, comment and editorials of the day
-
Trump HHS slashes advised child vaccinationsSpeed Read In a widely condemned move, the CDC will now recommend that children get vaccinated against 11 communicable diseases, not 17
-
A fentanyl vaccine may be on the horizonUnder the radar Taking a serious jab at the opioid epidemic
-
Health: Will Kennedy dismantle U.S. immunization policy?Feature ‘America’s vaccine playbook is being rewritten by people who don’t believe in them’
-
How dangerous is the ‘K’ strain super-flu?The Explainer Surge in cases of new variant H3N2 flu in UK and around the world
-
Vaccine critic quietly named CDC’s No. 2 officialSpeed Read Dr. Ralph Abraham joins another prominent vaccine critic, HHS Secretary Robert F. Kennedy Jr.
-
This flu season could be worse than usualIn the spotlight A new subvariant is infecting several countries
-
Covid-19 mRNA vaccines could help fight cancerUnder the radar They boost the immune system
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
